Wintermute Biomedical are excited our ZosterEase Phase Ib clinical trial’s patient recruitment is now fulfilled.
Preliminary safety results expected shortly. Read more here.
Preliminary safety results expected shortly. Read more here.
Get in touch with us
We seek to harness our platform to create real solutions to infectious diseases like Shingles. If you share our vision, we’d love to hear from you.